Health

Nutrition-focused program at home health agency beneficial

(HealthDay)—A nutrition-focused quality-improvement program (QIP) conducted in a home health agency (HHA) can reduce rates of hospitalization and health care resource utilization, according to a study published online June ...

Medications

U.S. lawmakers say WHO opioid guidelines too lax

The World Health Organization's pain care guidelines contain false claims about the safety of prescription opioid painkillers and should be withdrawn, two U.S. lawmakers say.

Psychology & Psychiatry

Rates of depression up in U.S. women at hospital to give birth

(HealthDay)—From 2000 to 2015, the rates of depressive disorders recorded for women during delivery hospitalization increased nationally, according to a study published online May 9 in Obstetrics & Gynecology.

Medications

Dabigatran doesn't beat aspirin for preventing recurrent stroke

(HealthDay)—Dabigatran is not superior to aspirin for preventing recurrent stroke in patients with recent history of embolic stroke of undetermined source, according to a study published in the May 16 issue of the New England ...

Autism spectrum disorders

Digital intervention ups socialization in children with autism

(HealthDay)—An artificial intelligence-driven wearable behavioral intervention, Superpower Glass, can improve social outcomes for children with autism spectrum disorder (ASD), according to a study published online March ...

Health

Notes reflecting financial considerations ID'd in ICU

(HealthDay)—Among patients in the intensive care unit (ICU), 4.2 percent of admissions have at least one note reflecting financial considerations, according to a study published online Nov. 2 in JAMA Network Open.

Health

Early readmissions more preventable than later ones

(HealthDay)—Early general medicine readmissions are more likely than late readmissions to be preventable with hospital-based interventions, according to a study published online May 1 in the Annals of Internal of Medicine.

Diseases, Conditions, Syndromes

Serlopitant found to be safe, effective for chronic pruritus

(HealthDay)—Serlopitant has potential as a therapy for the treatment of chronic pruritus, according to a study published in the May issue of the Journal of the American Academy of Dermatology.

page 7 from 33